Your browser doesn't support javascript.
loading
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07).
Satoh, Taroh; Kato, Ken; Ura, Takashi; Hamamoto, Yasuo; Kojima, Takashi; Tsushima, Takahiro; Hironaka, Shuichi; Hara, Hiroki; Iwasa, Satoru; Muro, Kei; Yasui, Hirofumi; Minashi, Keiko; Yamaguchi, Kensei; Ohtsu, Atsushi; Doki, Yuichiro; Matsumura, Yasuhiro; Kitagawa, Yuko.
Afiliación
  • Satoh T; Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, E21-19, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. taroh@cfs.med.osaka-u.ac.jp.
  • Kato K; Department of Head and Neck, Esophageal Medical Oncology / Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Ura T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Hamamoto Y; Department of Clinical Oncology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Kojima T; Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
  • Tsushima T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Hironaka S; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Hara H; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
  • Iwasa S; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan.
  • Muro K; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Yasui H; Department of Head and Neck, Esophageal Medical Oncology / Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Minashi K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yamaguchi K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ohtsu A; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
  • Doki Y; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Matsumura Y; Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kitagawa Y; National Cancer Center Hospital East, Kashiwa, Japan.
Esophagus ; 18(4): 835-843, 2021 10.
Article en En | MEDLINE | ID: mdl-33993388
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Esophagus Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Esophagus Año: 2021 Tipo del documento: Article País de afiliación: Japón